Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-700
Closed -$16K 10308
2014
Q2
$16K Buy
700
+100
+17% +$2.26K ﹤0.01% 8330
2014
Q1
$15K Sell
600
-900
-60% -$23.2K ﹤0.01% 8437
2013
Q4
$41K Sell
1,500
-200
-12% -$5.03K ﹤0.01% 7217
2013
Q3
$45K Sell
1,700
-800
-32% -$20.7K ﹤0.01% 6996
2013
Q2
$62K Buy
+2,500
New +$55.3K ﹤0.01% 6459

Other funds holding ADTN

UBS's ADTN Position: Q3 2014 in Review

UBS reduced its Adtran (ADTN) stake by 85% in Q3 2014, selling an estimated $6.45K and leaving 52 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10128.

UBS first reported a position in ADTN in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.64M in Q1 2014. 147 funds tracked by Wall St. Rank hold ADTN as of Q3 2014.

  • UBS held 52 shares of Adtran worth $1K as of Q3 2014.
  • UBS sold 288 Adtran shares in Q3 2014, an estimated $6.45K.
  • Adtran made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10128 holding.
  • UBS first reported a position in Adtran in Q2 2013 and has held it in 6 quarters since.
  • UBS's Adtran position peaked at $2.64M in Q1 2014.
  • 147 funds tracked by Wall St. Rank held Adtran as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.